Floxuridine
- Strength
- 100 mg/mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Class
- Antimetabolite
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Listed by JND Therapeutics, Inc.
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intra-arterial |
| Drug class | Antimetabolite |
| Approval route | ANDA — approved generic |
| NDC code | 81643-9270 |
| FDA application | ANDA075387 |
| RxNorm concept | 310351 |
| Package sizes listed | 1 |
| Marketed since | June 2022 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.